Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders
(Q37794058)
scientific article published on October 1, 2010
scientific article published on October 1, 2010
Language:
Current Data About
Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders